| # | Drug | Count |
|---|---|---|
| 0 | ARIPIPRAZOLE | 21 |
| 1 | ARIPIPRAZOLE ORAL | 19 |
| 2 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 19 |
| 3 | SERTRALINE | 18 |
| 4 | AZITHROMYCIN DIHYDRATE | 15 |
| 5 | VENLAFAXINE HYDROCHLORIDE | 14 |
| 6 | VENLAFAXINE | 12 |
| 7 | AZITHROMYCIN | 9 |
| 8 | AZITHROMYCIN MONOHYDRATE | 9 |
| 9 | CARBOPLATIN | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, FOLIC ACID, LEVOMEFOLATE CALCIUM, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, CALCIUM FORMATE, FERROUS ASPARTO GLYCINATE, MAGNESIUM OXIDE AND DOCONEXENT | 1 | 0.0476 |
| 1 | DEXRAZOXANE FOR INJECTION | 3 | 0.0032 |
| 2 | CHOLIC ACID | 1 | 0.0025 |
| 3 | TRIHEPTANOIN | 1 | 0.0018 |
| 4 | NITISINONE | 1 | 0.0010 |
| 5 | ONASEMNOGENE ABEPARVOVEC-XIOI | 2 | 0.0009 |
| 6 | PENICILLIN G | 2 | 0.0009 |
| 7 | CEFUROXIME SODIUM | 1 | 0.0008 |
| 8 | GLYCEROL PHENYLBUTYRATE | 1 | 0.0007 |
| 9 | GLUTATHIONE | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 24 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 11 |
| 2 | Platinum-based Drug [EPC] | 10 |
| 3 | Topoisomerase Inhibitor [EPC] | 9 |
| 4 | Alkylating Drug [EPC] | 8 |
| 5 | Corticosteroid [EPC] | 8 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 7 |
| 7 | Serotonin Reuptake Inhibitor [EPC] | 7 |
| 8 | Anti-epileptic Agent [EPC] | 6 |
| 9 | Vitamin C [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Medium-chain Triglyceride [EPC] | 1 | 0.0018 |
| 1 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 2 | Vitamin K [EPC] | 2 | 0.0002 |
| 3 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 4 | Topoisomerase Inhibitor [EPC] | 9 | 0.0001 |
| 5 | Recombinant Human Deoxyribonuclease 1 [EPC] | 2 | 0.0001 |
| 6 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 8 | Barbiturate [EPC] | 1 | 0.0001 |
| 9 | Serotonin Reuptake Inhibitor [EPC] | 7 | 0.0001 |